跳至主要内容
临床试验/NCT00501423
NCT00501423已完成不适用

Antiplatelet Drug Resistances and Ischemic Events

Pierre Fontana1 个研究点 分布在 1 个国家目标入组 771 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
771
试验地点
1
主要终点
MACE

研究概览

简要总结

The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.

详细描述

The ADRIE study is an observational study on the clinical relevance of platelet reactivity in aspirin and clopidogrel treated cardiovascular patients.

Main objective:

  • to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of ischemic events during the 3-year follow-up.

Secondary objectives:

  • primary outcome in each pre-specified sub-group : patients with coronary artery disease, ischemic stroke or peripheral arterial disease as main qualifying disease at entry,
  • to determine if platelet reactivity, assessed by specific and non-specific tests, is predictive of bleeding events during the 3-year follow-up,
  • to investigate potential determinants of platelet reactivity at entry in the study

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Documented symptomatic ischemic atherothrombotic disease treated by aspirin, clopidogrel or both.

排除标准

  • Known platelet disorder
  • Chronic treatment by antiplatelet drugs other than aspirin or clopidogrel.
  • Chronic anticoagulant treatment
  • Chronic non steroid anti inflammatory drug treatment
  • Active cancer
  • Ongoing aspirin or clopidogrel treatment taken for more than 5 years prior to inclusion

结局指标

主要结局

MACE

时间窗: prospective follow-up

adjudicating committee

次要结局

  • MACE in pre-specified sub-groups(prospective follow-up)

研究者

发起方
Pierre Fontana
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Pierre Fontana

PI

University Hospital, Geneva

研究点 (1)

Loading locations...

相似试验